Biotech Stocks Rally on New Breakthroughs

Biotech companies are flying high again. New cures and big drug buyouts are bringing cash back to these health stocks.

Scientists are finding fresh answers for hard diseases. Big drug makers are buying smaller research labs to grab their newest discoveries. These buyouts lift stock prices across the entire sector.

Wall Street analysts favor broad exchange-traded funds for this run. Basket funds spread out your risk, because single drug trials carry big swings.

Everyday investors can watch these medical wins for growth. Buying a diverse fund helps you join the boom while labs test their latest treatments.

Source: CNBC